HA

Hidaytullakhan Alibhai Bihari

Active Director Director DIN 10915973
DIN 10915973 First appointment Jan 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Hidaytullakhan Alibhai Bihari

Data last updated:

Hidaytullakhan Alibhai Bihari is a Director at Banas Pharmamach Private Limited (since 2025).

DIN 10915973
Primary Designation Director
First Appointment 21 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Banas Pharmamach Private Limited U26600GJ2025PTC158125
Director21 Jan 20252025Active

Board colleagues of Hidaytullakhan Alibhai Bihari

Directorship timeline

Open interactive timeline →
Banas Pharmamach Private Limited
Premium access

Shareholding and investment profile for Hidaytullakhan Alibhai Bihari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hidaytullakhan Alibhai Bihari

Hidaytullakhan Alibhai Bihari currently holds 1 directorship: Banas Pharmamach Private Limited (Director, since 21 Jan 2025).

Hidaytullakhan Alibhai Bihari was first appointed on 21 Jan 2025 as Director at Banas Pharmamach Private Limited.

The current boards of Hidaytullakhan Alibhai Bihari's companies include Asharafbhai Jamalbhai Arodiya (Banas Pharmamach Private Limited), Ismailbhai Nasirbhai Sunasara (Banas Pharmamach Private Limited), Jashwantkumar Mohanbhai Prajapati (Banas Pharmamach Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available